AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 31 filers reported holding AXSOME THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,686,000 | -39.4% | 301,000 | -39.9% | 0.20% | -50.1% |
| Q3 2017 | $2,781,000 | +0.9% | 501,000 | 0.0% | 0.40% | -15.2% |
| Q2 2017 | $2,756,000 | +76.2% | 501,000 | +24.9% | 0.47% | +52.9% |
| Q1 2017 | $1,564,000 | +66.7% | 401,000 | +267.7% | 0.31% | +50.7% |
| Q1 2016 | $938,000 | -53.3% | 109,069 | -50.4% | 0.20% | -31.0% |
| Q4 2015 | $2,009,000 | – | 220,000 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |